• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH DADE ACTIN FSL ACTIVATED PTT REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH DADE ACTIN FSL ACTIVATED PTT REAGENT Back to Search Results
Catalog Number B4219-2 SMN 10445714
Device Problem Use of Device Problem (1670)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/14/2016
Event Type  malfunction  
Manufacturer Narrative
The cause of the reported incident, the administration of an extra dose of heparin is the discrepancy between therapeutic range values for heparinized patients between two facilities.There is no indication of erroneous results reporting by the complainant facility, (b)(6).This first facility follows the general recommendations for performing heparin therapeutic range testing with every change between old and new lots of aptt reagents and tracking the cumulative difference between lots.Siemens healthcare has provided the second facility, (b)(6), with the 2014 siemens white-paper on therapeutic heparin testing to evaluate their current practices.The actin fsl aptt reagent is performing within specifications.No further evaluation of the device is required.
 
Event Description
A change in treatment which occurred due to differences in activated partial thromboplastin time (aptt) heparin therapeutic ranges between two hospital facilities.A patient with an aptt result within the therapeutic range at the first facility was transferred to a second hospital facility.A medic involved in the transfer regarded the aptt result as low relative to the heparin therapeutic range at the second hospital facility.The patient was administered an extra dose of heparin based on the difference in therapeutic ranges.There is no indication that patient treatment was altered or prescribed on the basis of the difference in therapeutic ranges or the additional heparin dose administered.There was no report of adverse health consequences as a result of the difference in therapeutic ranges or the additional heparin dose administered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DADE ACTIN FSL ACTIVATED PTT REAGENT
Type of Device
DADE ACTIN FSL ACTIVATED PTT REAGENT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil von behring strasse 76
marburg, D-350 41
GM  D-35041
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil von behring strasse 76
marburg, D-350 41
GM   D-35041
Manufacturer Contact
james morgera
glasgow business community
po box 6101
newark, DE 19714-6101
3026318356
MDR Report Key5651770
MDR Text Key45100024
Report Number9610806-2016-00018
Device Sequence Number1
Product Code GGW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K863594
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Medical Technologist
Type of Report Initial
Report Date 05/12/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/12/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date05/21/2017
Device Catalogue NumberB4219-2 SMN 10445714
Device Lot Number547468A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/14/2016
Date Device Manufactured07/02/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age60 YR
-
-